Adverse events in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A single center, real-world study in China.

被引：0
|
作者：
Xu, Chongrui
Tu, Hai-Yan
Sun, Yueli
Li, Yang-Si
Xu, Bingfei
Wang, Binchao
Chen, Hua-Jun
Wang, Zhen
Zhou, Qing
Yang, Jinji
Yang, Qi
Wu, Yi-Long
机构：
[1] South China Univ Technol, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci,Sch Med, Guangzhou, Peoples R China
[2] LinkDoc Beijing Technol Co Ltd, Beijing, Peoples R China
[3] Guangdong Prov Peoples Hosp & Guangdong Acad Med, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e21081
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21081
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy
    Matsuo, Norikazu
    Azuma, Koichi
    Kojima, Takashi
    Ishii, Hidenobu
    Tokito, Takaaki
    Yamada, Kazuhiko
    Hoshino, Tomoaki
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (04) : 1150 - 1158
  • [32] Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Huang, Derek De-Rui
    Liao, Bin-Chi
    Hsu, Wei-Hsun
    Yang, Ching-Yao
    Lin, Yen-Ting
    Wu, Shang-Gin
    Tsai, Tzu-Hsiu
    Chen, Kuan-Yu
    Ho, Chao-Chi
    Liao, Wei-Yu
    Shih, Jin-Yuan
    Yu, Chong-Jen
    Yang, James Chih-Hsin
    Cheng, Ann-Lii
    Shen, Ying-Chun
    ONCOLOGY, 2024, 102 (04) : 318 - 326
  • [33] Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy
    Norikazu Matsuo
    Koichi Azuma
    Takashi Kojima
    Hidenobu Ishii
    Takaaki Tokito
    Kazuhiko Yamada
    Tomoaki Hoshino
    Investigational New Drugs, 2021, 39 : 1150 - 1158
  • [34] Frequency of immune-related adverse events of immune-checkpoint inhibitors for non-small cell lung cancer in our single institution
    Chikamori, Kenichi
    Utsunomiya, Toshiaki
    Aoe, Keisuke
    Suetake, Ryo
    Ito, Kosuke
    Osoreda, Hisayuki
    Ikeda, Akihiko
    Tadashi, Maeda
    Kamei, Haruhito
    ANNALS OF ONCOLOGY, 2021, 32 : S325 - S325
  • [35] Real-world comparison of immune checkpoint inhibitors in non-small cell lung cancer following platinum-based chemotherapy
    Weis, Taylor M.
    Hough, Shannon
    Reddy, Haritha G.
    Daignault-Newton, Stephanie
    Kalemkerian, Gregory P.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (03) : 564 - 571
  • [36] Real-world effectiveness of immune checkpoint inhibitors alone or in combination with chemotherapy in metastatic non-small cell lung cancer.
    Hong, Lingzhi
    Rinsurongkawong, Waree
    Saad, Maliazurina B.
    Chen, Pingjun
    Aminu, Muhammad
    Spelman, Amy R.
    Negrao, Marcelo Vailati
    Cascone, Tina
    Lin, Steven H.
    Lee, Percy
    Sepesi, Boris
    Lewis, Jeff
    Gibbons, Don Lynn
    Vaporciyan, Ara A.
    Lee, J. Jack
    Le, Xiuning
    Wu, Jia
    Heymach, John
    Zhang, Jianjun
    Vokes, Natalie I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [38] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [39] Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum Chemotherapy
    Schwartzberg, Lee
    Korytowsky, Beata
    Penrod, John R.
    Zhang, Ying
    Le, T. Kim
    Batenchuk, Cory
    Krug, Lee
    CLINICAL LUNG CANCER, 2019, 20 (04) : 287 - +
  • [40] Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study
    Liguori, Luigi
    Giorgio, Gabriele
    Polcaro, Giovanna
    Pagliara, Valentina
    Malandrino, Domenico
    Perri, Francesco
    Cascella, Marco
    Ottaiano, Alessandro
    Conti, Valeria
    Servetto, Alberto
    Bianco, Roberto
    Pepe, Stefano
    Sabbatino, Francesco
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345